Advertisement
Screener

LendingTree, Inc. (TREE) Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount

2.8 / 5 stars · 68/120 Roast Me

LendingTree, Inc. Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount

LendingTree, Inc. (TREE) reported Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-09.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount · last filed 2026-03-09

  • LendingTree, Inc. equity securities without readily determinable fair value, impairment loss, annual amount for the quarter ending 2025-12-31 was -$1.23M.
  • LendingTree, Inc. equity securities without readily determinable fair value, impairment loss, annual amount for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
  • LendingTree, Inc. equity securities without readily determinable fair value, impairment loss, annual amount for the quarter ending 2025-06-30 was $1.20M.
  • LendingTree, Inc. equity securities without readily determinable fair value, impairment loss, annual amount for the quarter ending 2025-03-31 was $25.00K.
  • LendingTree, Inc. equity securities without readily determinable fair value, impairment loss, annual amount for fiscal 2025 was $0.00.
  • LendingTree, Inc. equity securities without readily determinable fair value, impairment loss, annual amount for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
  • LendingTree, Inc. equity securities without readily determinable fair value, impairment loss, annual amount for fiscal 2023 was $38.60M.
Period endEquity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 3 monthEquity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 6 monthEquity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 9 monthEquity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 12 month
2025-12-31-$1.23M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09
-$1.23M
derived: sum of 2 quarters · filed 2026-03-09
-$25.00K
derived: sum of 3 quarters · filed 2026-03-09
$0.00
10-K · filed 2026-03-09
2025-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-31
$1.20M
derived: sum of 2 quarters · filed 2025-10-31
$1.23M
10-Q · filed 2025-10-31
-$57.15M
derived: sum of 4 quarters · filed 2026-03-09
2025-06-30$1.20M
10-Q · filed 2025-10-31
$1.23M
10-Q · filed 2025-08-01
-$57.15M
derived: sum of 3 quarters · filed 2026-03-09
$1.23M
derived: sum of 4 quarters · filed 2026-03-09
2025-03-31$25.00K
derived: 10-K 12 month − 3 quarters · filed 2026-03-09
-$58.35M
derived: sum of 2 quarters · filed 2026-03-09
$25.00K
derived: sum of 3 quarters · filed 2026-03-09
2024-12-31-$58.38M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09
$0.00
derived: sum of 2 quarters · filed 2026-03-09
$0.00
10-K · filed 2026-03-09
2024-09-30$58.38M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-31
$58.38M
10-Q · filed 2025-10-31
2024-06-30$0.00
10-Q · filed 2025-08-01
2023-12-31-$75.90M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09
$37.20M
derived: sum of 2 quarters · filed 2026-03-09
$38.60M
derived: sum of 3 quarters · filed 2026-03-09
$38.60M
10-K · filed 2026-03-09
2023-09-30$113.10M
10-Q · filed 2024-11-04
$114.50M
derived: sum of 2 quarters · filed 2026-03-09
$114.50M
10-Q · filed 2024-11-04
2023-06-30$1.40M
10-K · filed 2026-03-09
$1.44M
10-Q · filed 2024-07-29
2022-12-31$0.00
derived: 10-Q 12 month − 10-Q 9 month · filed 2023-11-01
$0.00
derived: sum of 2 quarters · filed 2023-11-01
$0.00
10-Q · filed 2023-11-01
2022-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01
$0.00
10-Q · filed 2023-11-01
2022-06-30$0.00
10-Q · filed 2023-07-28